Literature DB >> 19546360

Antimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori isolates from patients in the western central region of Colombia.

Adalucy Alvarez1, José Ignacio Moncayo, Jorge Javier Santacruz, Mario Santacoloma, Luisa Fernanda Corredor, Elizabeth Reinosa.   

Abstract

Resistance to metronidazole, clarithromycin, and amoxicillin (amoxicilline) was found in 82, 3.8, and 1.9% of 106 Helicobacter pylori isolates, respectively. No tetracycline-resistant isolates were found. In all of the clarithromycin-resistant isolates, only one point mutation was present, either A2143G or A2142G. Our results indicate that metronidazole should not be included in the empirical treatment of H. pylori infection in this region.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19546360      PMCID： PMC2737890          DOI： 10.1128/AAC.00145-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  25 in total

1.  PCR-restriction fragment length polymorphism can also detect point mutation A2142C in the 23S rRNA gene, associated with Helicobacter pylori resistance to clarithromycin.

Authors:  Armelle Ménard; Adriana Santos; Francis Mégraud; Mónica Oleastro
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

2.  Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori.

Authors:  Y Glupczynski; N Broutet; A Cantagrel; L P Andersen; T Alarcon; M López-Brea; F Mégraud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-06-28       Impact factor: 3.267

3.  Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico.

Authors:  J Torres; M Camorlinga-Ponce; G Pérez-Pérez; A Madrazo-De la Garza; M Dehesa; G González-Valencia; O Muñoz
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

4.  Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil.

Authors:  S Mendonça; C Ecclissato; M S Sartori; A P Godoy; R A Guerzoni; M Degger; J Pedrazzoli
Journal:  Helicobacter       Date:  2000-06       Impact factor: 5.753

Review 5.  Treatment of Helicobacter pylori.

Authors:  K Wolle; P Malfertheiner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2007       Impact factor: 3.043

6.  [In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin].

Authors:  C González; A García; F Daroch; F Kawaguchi; H Solar; N Rivera; E Vega
Journal:  Rev Med Chil       Date:  2001-06       Impact factor: 0.553

7.  Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods.

Authors:  L M Best; D J M Haldane; M Keelan; D E Taylor; A B R Thomson; V Loo; C A Fallone; P Lyn; F M Smaill; R Hunt; C Gaudreau; J Kennedy; M Alfa; R Pelletier; S J O Veldhuyzen Van Zanten
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

8.  Characteristics of clinical Helicobacter pylori strains from Ecuador.

Authors:  Yvette J Debets-Ossenkopp; Germán Reyes; Janet Mulder; Birgit M aan de Stegge; José T A M Peters; Paul H M Savelkoul; J Tanca; Amado S Peña; Christina M J E Vandenbroucke-Grauls
Journal:  J Antimicrob Chemother       Date:  2003-01       Impact factor: 5.790

9.  The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections.

Authors:  Brian J McMahon; Thomas W Hennessy; J Michael Bensler; Dana L Bruden; Alan J Parkinson; Julie M Morris; Alisa L Reasonover; Debby A Hurlburt; Michael G Bruce; Frank Sacco; Jay C Butler
Journal:  Ann Intern Med       Date:  2003-09-16       Impact factor: 25.391

10.  Clarithromycin resistance among Helicobacter pylori strains isolated from children: prevalence and study of mechanism of resistance by PCR-restriction fragment length polymorphism analysis.

Authors:  Teresa Alarcón; Alba E Vega; Diego Domingo; Maria Josefa Martínez; Manuel López-Brea
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948
View more
  13 in total

1.  Phenotypic and genotypic analysis of clarithromycin-resistant Helicobacter pylori from Bogotá D.C., Colombia.

Authors:  Alba A Trespalacios; William Otero; Jorge E Caminos; Marcela M Mercado; Jenny Avila; Liliana E Rosero; Azucena Arévalo; Raúl A Poutou-Piñales; David Y Graham
Journal:  J Microbiol       Date:  2013-08-30       Impact factor: 3.422

2.  Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran.

Authors:  Shohreh Farshad; Abdolvahab Alborzi; Aziz Japoni; Reza Ranjbar; Kazem Hosseini Asl; Parisa Badiee; Maneli Amin Shahidi; Marziyeh Hosseini
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

3.  Rapid detection of clarithromycin resistant Helicobacter pylori strains in Spanish patients by polymerase chain reaction-restriction fragment length polymorphism.

Authors:  S Agudo; G Pérez-Pérez; T Alarcón; M López-Brea
Journal:  Rev Esp Quimioter       Date:  2011-03       Impact factor: 1.553

Review 4.  Clinical practice: Helicobacter pylori infection in childhood.

Authors:  Deniz Ertem
Journal:  Eur J Pediatr       Date:  2012-09-27       Impact factor: 3.183

5.  14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.

Authors:  E Robert Greenberg; Garnet L Anderson; Douglas R Morgan; Javier Torres; William D Chey; Luis Eduardo Bravo; Ricardo L Dominguez; Catterina Ferreccio; Rolando Herrero; Eduardo C Lazcano-Ponce; María Mercedes Meza-Montenegro; Rodolfo Peña; Edgar M Peña; Eduardo Salazar-Martínez; Pelayo Correa; María Elena Martínez; Manuel Valdivieso; Gary E Goodman; John J Crowley; Laurence H Baker
Journal:  Lancet       Date:  2011-07-21       Impact factor: 79.321

6.  High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain.

Authors:  Sonia Agudo; Guillermo Pérez-Pérez; Teresa Alarcón; Manuel López-Brea
Journal:  J Clin Microbiol       Date:  2010-07-28       Impact factor: 5.948

7.  Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study.

Authors:  Khansa Ben Mansour; Christophe Burucoa; Meriem Zribi; Afef Masmoudi; Sami Karoui; Lamia Kallel; Soufiène Chouaib; Samira Matri; Monia Fekih; Sonia Zarrouk; Mounir Labbene; Jalel Boubaker; Imed Cheikh; Mongi Ben Hriz; Nadia Siala; Abdelkarim Ayadi; Azza Filali; Nabil Ben Mami; Taoufik Najjar; Ahmed Maherzi; Mohamed Tahar Sfar; Chedlia Fendri
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-08-13       Impact factor: 3.944

8.  Antimicrobial susceptibility testing for Helicobacter pylori isolates from Brazilian children and adolescents: comparing agar dilution, E-test, and disk diffusion.

Authors:  Silvio Kazuo Ogata; Ana Cristina Gales; Elisabete Kawakami
Journal:  Braz J Microbiol       Date:  2015-03-04       Impact factor: 2.476

9.  Detection of 23SrRNA Mutations Strongly Related to Clarithromycin Resistance in Helicobacter pylori Strains Isolated From Patients in the North of Iran.

Authors:  Zahra Eghbali; Ali Mojtahedi; Malek Moien Ansar; Saba Fakhrieh Asl; Keyvan Aminian
Journal:  Jundishapur J Microbiol       Date:  2016-02-15       Impact factor: 0.747

10.  Evaluation of Clarithromycin Resistance Among Iranian Helicobacter pylori Isolates by E-Test and Real-Time Polymerase Chain Reaction Methods.

Authors:  Mojdeh Hakemi Vala; Shirin Eyvazi; Hossein Goudarzi; Hamid Reza Sarie; Mehrdad Gholami
Journal:  Jundishapur J Microbiol       Date:  2016-03-19       Impact factor: 0.747
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.